questionsmedicales.fr
Cellules
Cellules épithéliales
Cellules endothéliales
Cellules endothéliales : Questions médicales fréquentes
Termes MeSH sélectionnés :
Drug Administration Schedule
Diagnostic
5
Dysfonction endothéliale
Échographie Doppler
Protéine C-réactive
Cytokines
Angiographie
Imagerie par résonance magnétique
Symptômes
5
Dysfonction endothéliale
Œdème
Athérosclérose
Essoufflement
Thrombose veineuse
Douleur
Prévention
5
Mode de vie sain
Alimentation équilibrée
Tabagisme
Aliments anti-inflammatoires
Cholestérol
Activité physique
Diabète
Graisses saturées
Traitements
5
Statines
Changements de mode de vie
Anti-inflammatoires
Corticostéroïdes
Anticoagulants
Antiplaquettaires
Ischémie chronique
Chirurgie
Complications
5
Maladies cardiovasculaires
AVC
Thrombose
Maladies auto-immunes
Crise cardiaque
Douleurs angineuses
Embolie pulmonaire
Thrombose veineuse
Lésions tissulaires
Gangrène
Facteurs de risque
5
Cholestérol LDL
Maladies vasculaires
Inactivité physique
Maladies cardiovasculaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cellules endothéliales : Questions médicales les plus fréquentes",
"headline": "Cellules endothéliales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cellules endothéliales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cellules épithéliales",
"url": "https://questionsmedicales.fr/mesh/D004847",
"about": {
"@type": "MedicalCondition",
"name": "Cellules épithéliales",
"code": {
"@type": "MedicalCode",
"code": "D004847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Progéniteurs endothéliaux",
"alternateName": "Endothelial Progenitor Cells",
"url": "https://questionsmedicales.fr/mesh/D066026",
"about": {
"@type": "MedicalCondition",
"name": "Progéniteurs endothéliaux",
"code": {
"@type": "MedicalCode",
"code": "D066026",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.182"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cellules endothéliales de la veine ombilicale humaine",
"alternateName": "Human Umbilical Vein Endothelial Cells",
"url": "https://questionsmedicales.fr/mesh/D061307",
"about": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales de la veine ombilicale humaine",
"code": {
"@type": "MedicalCode",
"code": "D061307",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.682"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Podosomes",
"alternateName": "Podosomes",
"url": "https://questionsmedicales.fr/mesh/D000069261",
"about": {
"@type": "MedicalCondition",
"name": "Podosomes",
"code": {
"@type": "MedicalCode",
"code": "D000069261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.436.275.841"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cellules endothéliales",
"alternateName": "Endothelial Cells",
"code": {
"@type": "MedicalCode",
"code": "D042783",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter Carmeliet",
"url": "https://questionsmedicales.fr/author/Peter%20Carmeliet",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be."
}
},
{
"@type": "Person",
"name": "Kim D Falkenberg",
"url": "https://questionsmedicales.fr/author/Kim%20D%20Falkenberg",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Katerina Rohlenova",
"url": "https://questionsmedicales.fr/author/Katerina%20Rohlenova",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium."
}
},
{
"@type": "Person",
"name": "Yonglun Luo",
"url": "https://questionsmedicales.fr/author/Yonglun%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China."
}
},
{
"@type": "Person",
"name": "Walter Muranyi",
"url": "https://questionsmedicales.fr/author/Walter%20Muranyi",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Online scheduling using a fixed template: the case of outpatient chemotherapy drug administration.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36319888",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10729-022-09616-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elotuzumab: Empiric analysis of dexamethasone administration schedule.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/37876226",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/10781552231207855"
}
},
{
"@type": "ScholarlyArticle",
"name": "NASN's Medication Administration Clinical Guideline.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35567332",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/1942602X221098735"
}
},
{
"@type": "ScholarlyArticle",
"name": "Strategies for cessation of caffeine administration in preterm infants.",
"datePublished": "2024-07-24",
"url": "https://questionsmedicales.fr/article/39045901",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/14651858.CD015802.pub2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Biweekly administration of cetuximab in Japanese patients with recurrent or metastatic head and neck cancer.",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/35943644",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10147-022-02226-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Cellules épithéliales",
"item": "https://questionsmedicales.fr/mesh/D004847"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cellules endothéliales",
"item": "https://questionsmedicales.fr/mesh/D042783"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cellules endothéliales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cellules endothéliales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cellules endothéliales",
"description": "Comment diagnostiquer une dysfonction endothéliale ?\nQuels examens pour évaluer les cellules endothéliales ?\nQuels marqueurs biologiques indiquent une inflammation endothéliale ?\nComment évaluer la perméabilité endothéliale ?\nQuels tests pour détecter des lésions endothéliales ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cellules endothéliales",
"description": "Quels symptômes indiquent une dysfonction endothéliale ?\nComment reconnaître une inflammation endothéliale ?\nQuels signes cliniques d'athérosclérose ?\nQuels symptômes d'une thrombose veineuse ?\nComment se manifeste une ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cellules endothéliales",
"description": "Comment prévenir la dysfonction endothéliale ?\nQuelles habitudes pour réduire l'inflammation ?\nComment prévenir l'athérosclérose ?\nQuelles mesures pour éviter la thrombose ?\nComment réduire le risque d'ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cellules endothéliales",
"description": "Quels traitements pour la dysfonction endothéliale ?\nComment traiter l'inflammation endothéliale ?\nQuelles interventions pour l'athérosclérose ?\nQuels médicaments pour prévenir la thrombose ?\nComment gérer l'ischémie chronique ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cellules endothéliales",
"description": "Quelles complications de la dysfonction endothéliale ?\nQuels risques liés à l'inflammation endothéliale ?\nQuelles complications de l'athérosclérose ?\nQuels dangers d'une thrombose veineuse ?\nQuelles complications de l'ischémie ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cellules endothéliales",
"description": "Quels facteurs de risque pour la dysfonction endothéliale ?\nComment le stress influence-t-il l'endothélium ?\nQuels rôles du cholestérol dans la santé endothéliale ?\nComment l'alimentation affecte-t-elle l'endothélium ?\nQuels impacts de l'inactivité physique sur l'endothélium ?",
"url": "https://questionsmedicales.fr/mesh/D042783?mesh_terms=Drug+Administration+Schedule#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction endothéliale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'échographie Doppler et les marqueurs sanguins peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer les cellules endothéliales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les biopsies tissulaires et les analyses histologiques sont couramment pratiquées."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques indiquent une inflammation endothéliale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs comme la protéine C-réactive et les cytokines peuvent être mesurés."
}
},
{
"@type": "Question",
"name": "Comment évaluer la perméabilité endothéliale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de perméabilité utilisant des colorants ou des marqueurs radioactifs sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests pour détecter des lésions endothéliales ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'angiographie et l'imagerie par résonance magnétique peuvent révéler des lésions."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une dysfonction endothéliale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs thoraciques, des troubles circulatoires et des œdèmes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une inflammation endothéliale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur et gonflement au site affecté sont des signes d'inflammation."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques d'athérosclérose ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs dans la poitrine, fatigue et essoufflement peuvent indiquer une athérosclérose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une thrombose veineuse ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gonflement, douleur et rougeur dans la zone touchée sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une ischémie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ischémie se manifeste par des douleurs, des engourdissements et une faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir la dysfonction endothéliale ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est essentiel."
}
},
{
"@type": "Question",
"name": "Quelles habitudes pour réduire l'inflammation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabac, réduire le stress et consommer des aliments anti-inflammatoires aide."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'athérosclérose ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Contrôler la pression artérielle, le cholestérol et pratiquer une activité physique régulière."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter la thrombose ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rester actif, s'hydrater et éviter de rester immobile longtemps sont des mesures préventives."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque d'ischémie ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gérer le diabète, contrôler le poids et éviter les aliments riches en graisses saturées."
}
},
{
"@type": "Question",
"name": "Quels traitements pour la dysfonction endothéliale ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les statines et des changements de mode de vie sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment traiter l'inflammation endothéliale ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anti-inflammatoires et des corticostéroïdes peuvent être prescrits selon la gravité."
}
},
{
"@type": "Question",
"name": "Quelles interventions pour l'athérosclérose ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des procédures comme l'angioplastie ou le pontage peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour prévenir la thrombose ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et les antiplaquettaires sont souvent utilisés pour prévenir la thrombose."
}
},
{
"@type": "Question",
"name": "Comment gérer l'ischémie chronique ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements médicaux, des exercices et parfois une chirurgie sont envisagés."
}
},
{
"@type": "Question",
"name": "Quelles complications de la dysfonction endothéliale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut entraîner des maladies cardiovasculaires, des AVC et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Quels risques liés à l'inflammation endothéliale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'inflammation peut provoquer des thromboses, des embolies et des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'athérosclérose ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut mener à des crises cardiaques, des AVC et des douleurs angineuses."
}
},
{
"@type": "Question",
"name": "Quels dangers d'une thrombose veineuse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une thrombose peut provoquer une embolie pulmonaire, mettant en danger la vie."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'ischémie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ischémie peut entraîner des lésions tissulaires, des gangrènes et des amputations."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la dysfonction endothéliale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hypertension, le diabète, le tabagisme et l'obésité augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il l'endothélium ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut aggraver l'inflammation et la dysfonction endothéliale."
}
},
{
"@type": "Question",
"name": "Quels rôles du cholestérol dans la santé endothéliale ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux élevé de cholestérol LDL est un facteur de risque majeur pour les maladies vasculaires."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation affecte-t-elle l'endothélium ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en graisses saturées et en sucres peut nuire à la fonction endothéliale."
}
},
{
"@type": "Question",
"name": "Quels impacts de l'inactivité physique sur l'endothélium ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le manque d'exercice physique contribue à la dysfonction endothéliale et aux maladies cardiovasculaires."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium. peter.carmeliet@kuleuven.vib.be.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Angiogenesis and Vascular Metabolism, Department of Oncology, KU Leuven, Leuven, Belgium.
Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology, VIB, Leuven, Belgium.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Lars Bolund Institute of Regenerative Medicine, BGI-Qindao, Qindao, China.
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
BGI-Shenzhen, Shenzhen, China.
China National GeneBank, BGI-Shenzhen, Shenzhen, China.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Pediatric Infectious Diseases, Medical Faculty Mannheim, Heidelberg University, 68167, Mannheim, Germany. christian.schwerk@medma.uni-heidelberg.de.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN.
Lions Gift of Sight Eye Bank, St. Paul, MN.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, MN.
Lions Gift of Sight Eye Bank, St. Paul, MN.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Affiliations :
Integrative Vascular Biology Laboratory, Department of Integrative Physiology, University of Colorado, Boulder, Colorado.
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
2 publications dans cette catégorie
Publications dans "Cellules endothéliales" :
1 publication dans cette catégorie
Affiliations :
University of California Merced, Graduate Program in Quantitative and Systems Biology, Merced, California, United States; slimbu@ucmerced.edu.
Publications dans "Cellules endothéliales" :
1 publication dans cette catégorie
Affiliations :
University of California Merced, School of Engineering, 5200 N Lake Rd, Merced, Merced, California, United States, 95343-5001; kmccloskey@ucmerced.edu.
Publications dans "Cellules endothéliales" :
In this paper, we use a fixed template of slots for the online scheduling of appointments. The template is a link between planning the service capacity at a tactical level and online scheduling at an ...
Elotuzumab in combination with dexamethasone and immunomodulating agents (IMiDs) lenalidomide or pomalidomide is 2nd to 4th line therapy for multiple myeloma. The labelled dosage of dexamethasone for ...
Despite the volume of medications that are administered in schools, school nurse guidelines for administering medications in schools lacked the support of empirical literature to guide best practices....
Apnea and intermittent hypoxemia (IH) are common developmental disorders in infants born earlier than 37 weeks' gestation. Caffeine administration has been shown to lower the incidence of these disord...
To evaluate the effects of early versus late discontinuation of caffeine administration in preterm infants....
We searched CENTRAL, PubMed, Embase, and three trial registries in August 2023; we applied no date limits. We checked the references of included studies and related systematic reviews....
We included randomized controlled trials (RCTs) in preterm infants born earlier than 37 weeks' gestation, up to a PMA of 44 weeks and 0 days, who received caffeine for any indication for at least seve...
We used standard Cochrane methods. Primary outcomes were: restarting caffeine therapy, intubation within one week of treatment discontinuation, and the need for non-invasive respiratory support within...
We included three RCTs (392 preterm infants). Discontinuation of caffeine at PMA less than 35 weeks' gestation versus PMA equal to or longer than 35 weeks' gestation This comparison included one singl...
There may be little or no difference in the incidence of all-cause mortality and apnea in infants who were randomized to later discontinuation of caffeine treatment. However, the number of infants wit...
Cetuximab (Cmab) plays an important role in the treatment for recurrent or metastatic head and neck cancer (R/M HNC). To date, however, no safety data on biweekly administration of cetuximab at a dose...
We retrospectively reviewed the clinical records of five R/M HNC patients who received biweekly Cmab in our institute between January 2016 and September 2021 and compared the safety profile between tw...
All patients initially received Cmab in combination with chemotherapy. Chemotherapy consisted of paclitaxel plus carboplatin in two patients, cisplatin + 5-FU in one patient, and paclitaxel in two pat...
Biweekly Cmab was well tolerated and did not demonstrate severe toxicities related to Cmab for R/M HNC....
Tyrosine kinase inhibitors (TKIs) have demonstrated significant efficacy against various types of cancers through molecular targeting mechanisms. Over the past 22 years, more than 100 TKIs have been a...
The standard meropenem (MEPM) regimen allowed by insurance in Japan is 0.5 g two or three times a day. Differences in dosages and administration schedules in Japan were evaluated....
Patients with bacteremia for whom MEPM was used as the initial treatment at our institution between 2016 and 2021 were included. We retrospectively investigated patients classified into two groups: th...
The probability of 100% fT > MIC was significantly higher in the high-dose group (96.4% vs 74.5%, odds ratio [OR] = 0.3, 95% confidence interval [CI] = 0.2-0.4, P = < 0.001). Regarding outcomes, the 3...
To improve outcomes in patients with bacteremia treated with MEPM, support for appropriate antimicrobial use is necessary for compliance with the dosage and administration schedule according to severe...
The growing evidence detailing the harmful effects of exposure to antibiotics has driven an urgency to evaluate recommendations in common pediatric infections regarding antibiotic course duration and ...
The optimal timing of tocilizumab treatment during the disease course of COVID-19 has yet to be adequately defined in the context of randomised controlled trials and the effect of tocilizumab on real-...
All adults (≥18 years old) with confirmed COVID-19 admitted to four hospitals in the West of Scotland between 8 January 2021 and 31 March 2021 and who received tocilizumab were included in a retrospec...
203 patients were included in the analysis (138 in the early cohort, 65 in the late cohort). Mortality in 90 days in the early cohort was 22% (n=30) compared with 45% (n=29) in the late cohort (p<0.00...
Early administration of tocilizumab within the first 2 days of hospitalisation was associated with a significant survival benefit compared with late exposure. Late administration was associated with p...
Hospice and palliative care have been shown to increase patient satisfaction and improve symptom control at the end of life. Opioid analgesics are typically given around the clock at the end of life t...
This was a retrospective, quasi-experimental study at a 766-bed community hospital with hospice and palliative care services. Adult patients admitted to inpatient hospice care with active orders for s...
A total of 75 patients were included in the final analysis. The rate of missed doses was 5% in the pre-implementation cohort and 4% in the post-implementation cohort (...
The creation and dissemination of nursing education were not associated with a decrease in missed or delayed doses of scheduled opioids in hospice patients....